Global X S&P Biotech ETF
CURE
Global X S&P Biotech ETF CURE Strategy
The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index.
The investment objective & strategy is a summary of the investment's principal strategy as written in the prospectus. This information is pulled from the most recent product disclosure document.
Global X S&P Biotech ETF News & Analysis
etfs
Thematic ETFs: short-lived trend or long-term investment?
Battery technology. Cybersecurity. Cloud Computing. Exchange-traded funds that focus on a niche sector are in vogue and worth considering but brace for a high-risk/high-reward ride.
etfs
Spotlight on 4 thematic ETFs
These four exchange-traded funds tap into key themes on the international investing landscape: biotech, China's new economy, AI and lithium.
etfs
Thematic ETFs are hot, until they're not
These days there seems to be an exchange-traded fund for every emerging trend and while they are convenient, they are no guarantee of value and growth.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,471.50 | 18.80 | 0.22% |
| CAC 40 | 7,282.69 | 10.37 | 0.14% |
| DAX 40 | 19,848.77 | 35.98 | -0.18% |
| Dow JONES (US) | 43,268.49 | 28.54 | -0.07% |
| FTSE 100 | 8,136.99 | 34.27 | 0.42% |
| HKSE | 20,098.29 | 215.16 | 1.08% |
| NASDAQ | 20,015.32 | 15.81 | -0.08% |
| Nikkei 225 | 39,568.06 | 437.63 | 1.12% |
| NZX 50 Index | 13,074.74 | 86.71 | 0.67% |
| S&P 500 | 6,033.64 | 6.40 | -0.11% |
| S&P/ASX 200 | 8,220.90 | 19.30 | 0.24% |
| SSE Composite Index | 3,393.53 | 42.27 | 1.26% |